Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2016 - 2025)
Sonoma Pharmaceuticals has reported Other Working Capital Changes over the past 16 years, most recently at $392000.0 for Q4 2025.
- For Q4 2025, Other Working Capital Changes rose 622122.22% year-over-year to $392000.0; the TTM value through Dec 2025 reached -$231000.0, down 366766.67%, while the annual FY2025 figure was $94.0, 99.34% down from the prior year.
- Other Working Capital Changes for Q4 2025 was $392000.0 at Sonoma Pharmaceuticals, up from $386000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.0 million in Q1 2023 and troughed at -$1.0 million in Q1 2024.
- A 5-year average of $40955.4 and a median of $5000.0 in 2023 define the central range for Other Working Capital Changes.
- Biggest five-year swings in Other Working Capital Changes: tumbled 197.77% in 2024 and later soared 3859900.0% in 2025.
- Year by year, Other Working Capital Changes stood at $13996.0 in 2021, then soared by 68.66% to $23605.0 in 2022, then crashed by 78.82% to $5000.0 in 2023, then plummeted by 98.74% to $63.0 in 2024, then surged by 622122.22% to $392000.0 in 2025.
- Business Quant data shows Other Working Capital Changes for SNOA at $392000.0 in Q4 2025, $386000.0 in Q3 2025, and -$950000.0 in Q1 2025.